While precision oncology requires robust biomarkers, current predictors for lung adenocarcinoma (LUAD) often show limited clinical utility. This study investigates the multifaceted roles of ZC3H12D, a ...

The researchers described the unprecedented speed of the oversight steps as being "through alternative procedures." In month ...